Immucell OverviewImmucell EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ICCC.
Quarterly EBIT
$1.97M
↓ 99.82% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
$2.56M
↓ 99.53% YoY
Trailing 12 months ending Mar 31, 2026
Immucell OverviewEBIT (Earnings Before Interest and Taxes) analysis for ICCC.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026